Clinical Trials Logo

Clinical Trial Summary

The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of Subiculum as adjunctive therapy for reducing the frequency of seizures in drug-resistant temporal lobe epilepsy with bilateral hippocampal sclerosis


Clinical Trial Description

This project aims to include 6 participants, and evaluate the effectiveness and safety of bilateral hippocampal subcortical stimulation in patients with temporal lobe epilepsy and bilateral hippocampal sclerosis through A prospective, interventional, unblinded, single-arm clinical trial. It is expected to provide new therapeutic options for patients with temporal lobe epilepsy and bilateral hippocampal sclerosis with alternative treatment options. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06436547
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact Liankun Ren, MD
Phone +86 13681576621
Email renlk2022@outlook.com
Status Not yet recruiting
Phase N/A
Start date May 30, 2024
Completion date July 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT03183076 - Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy N/A
Completed NCT04181229 - Deep Brain Stimulation Post Failed Vagal Nerve Stimulation N/A
Recruiting NCT04673071 - Effectiveness and Safety of Thread Embedding Acupuncture for Drug Resistant Epilepsy N/A
Recruiting NCT04166305 - Drug Resistant Epilepsy: Clinical and Genetic Study
Not yet recruiting NCT06364085 - Enhancing Epilepsy Management With Precision Deep Brain Stimulation N/A
Completed NCT03860298 - Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy N/A
Recruiting NCT06248333 - Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy N/A